Asimov builds tools to program living cells. Our mammalian cell engineering platform advances the design and manufacture of biologics and gene therapies. The Asimov lentiviral producer cell line service delivers monoclonal suspension HEK293T-based inducible cell lines containing all necessary elements for VSV-G pseudotyped lentivirus production. The cell line development process takes 3-4 months from DNA synthesis to research cell bank. This process eliminates the need for multiple costly and time-consuming GMP-grade plasmid batches throughout the clinical and commercial stages.